<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0215">
 <label>43</label>
 <element-citation publication-type="journal" id="rf0195">
  <person-group person-group-type="author">
   <name>
    <surname>South</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Tomlinson</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Edmonston</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Hiremath</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Sparks</surname>
    <given-names>M.A.</given-names>
   </name>
  </person-group>
  <article-title>Controversies of reninâ€“angiotensin system inhibition during the COVID-19 pandemic</article-title>
  <source>Nat. Rev. Nephrol.</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1038/s41581-020-0279-4</pub-id>
 </element-citation>
</ref>
